Australia Mammography - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The australia mammography market size is projected to expand from USD 69.78 million in 2025 and USD 75.59 million in 2026 to USD 117.75 million by 2031, registering a CAGR of 9.27% between 2026 to 2031. This report is Segmented by Product and Services (Mammography Systems, Accessories and Consumables, Software, Platforms and Services), Technology (Full-Field Digital Mammography, Digital Breast Tomosynthesis, Contrast-Enhanced Spectral Mammography, AI-Enabled CAD & Image-Triage, Photon-Counting Digital), End User (Hospitals, and More). Market Forecasts are Provided in Terms of Value (USD).

Australia Mammography Market Trends and Insights

Rising Breast Cancer Incidence & Screening Targets

Australia logged 20,336 new breast-cancer diagnoses in 2025, sustaining policy pressure to lift BreastScreen participation toward the 70% goal that remains well out of reach at 49.6%. Indigenous participation sits even lower at 34.9%, prompting federal and state funding for mobile digital units that beam images to city radiologists. Five-year survival of 93% underlines the payoff from early detection, bolstering the case for additional mammography capacity. The forthcoming BreastScreen policy review is expected to link state funding to incremental participation gains, adding tailwinds for equipment orders. Closing the participation gap implies around 200,000 extra screens a year, which equates to 15-20 new systems if each unit handles 5,000 exams annually.

MBS Reimbursement for Digital & 3-D Upgrades

November 2025 reforms limit DBT claims to dense-breast or high-risk patients, yet the change drives hospitals to install density-assessment software that certifies eligibility and secures the AUD 150 (USD 100) higher reimbursement per study. Facilities mitigate the AUD 500,000-700,000 capital burden by pursuing volume deals with general-practice networks that fill schedules. Private radiology groups that once offered fee-for-service DBT now pivot to MBS-compliant pathways, which stabilize revenue but raise competition for the smaller qualifying cohort. The result is cautious hardware demand paired with robust software uptake.

High Capital & Lifecycle Cost of DBT Systems

DBT units cost AUD 500,000-700,000 and require annual service contracts near AUD 50,000, double the outlay for 2D systems. With fewer than 3,000 screens per year, many regional hospitals face payback periods beyond the typical 7-year cycle, deterring upgrades. Larger data sets inflate storage and network expenses, and private centers without bulk-buy leverage defer investments in favor of software retrofits.

Other drivers and restraints analyzed in the detailed report include:

• Technology Shift to DBT & AI-Assisted Reading
• Risk-Based Screening & Density Notification Pilots
• Radiologist & Technologist Workforce Shortages

Segment Analysis

Mammography Systems still captured 73.64% of 2025 revenue, yet the category’s share is slipping as providers lengthen replacement intervals and retrofit existing units with AI modules. Software, Platforms & Services is advancing at a 13.64% CAGR, reflecting demand for cloud archiving, density analytics, and computer-aided detection that address workforce shortages. Hologic licenses Genius AI Detection at about AUD 30,000 per year, letting hospitals delay full upgrades while boosting sensitivity. Volpara’s per-study fees turn screening volume directly into SaaS revenue, offering resilience against hardware-cycle swings. The mammography market size attributed to Accessories & Consumables remains a stable mid-single-digit slice, tied closely to screen volume rather than technology mix.

Second-order effects reinforce the pivot. Draft national imaging standards specify automated dose logging and phantom tracking, functions delivered through software rather than hardware. Public hospitals in NSW and Victoria negotiate enterprise licenses that cap per-study costs, while smaller private clinics accept per-click billing to avoid upfront fees. This migration to recurring models improves cash flow for vendors and aligns expenses with utilization for providers, advancing a service-led trajectory in the mammography market.

Complete Report Scope:

• By Product and Services
  • Mammography Systems
  • Accessories and Consumables
  • Software, Platforms and Services
• By Technology
  • Full-Field Digital Mammography (FFDM - 2D)
  • Digital Breast Tomosynthesis (3D)
  • Contrast-Enhanced Spectral Mammography (CESM)
  • AI-enabled CAD & Image-triage
  • Photon-counting Digital
• By End User
  • Hospitals
  • Diagnostic Centers
  • Specialty Clinics
  • Others

List of Companies Covered in this Report:

• Agfa-Gevaert
• Canon Medical
• Carestream Health
• FUJIFILM
• GE Healthcare
• Hologic
• Integral Diagnostics
• Konica Minolta
• Koninklijke Philips
• Micro-X Ltd
• Mindray Bio-medical
• Koninklijke Philips
• Planmed
• Samsung Group
• Siemens Healthineers
• United Imaging Healthcare
• Volpara Health Technologies

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support